Immunotherapy Boost for Bile Duct Cancer Survival Holds Firm After Three Years
Three-year follow-up of the phase 3 KEYNOTE-966 trial confirms that adding pembrolizumab to gemcitabine and cisplatin chemotherapy maintains a durable ...
Three-year follow-up of the phase 3 KEYNOTE-966 trial confirms that adding pembrolizumab to gemcitabine and cisplatin chemotherapy maintains a durable ...
A Japanese retrospective study of 244 thoracic cancer patients finds that baseline hypertension triples the risk of cisplatin-induced kidney injury ...
A cross-sectional study of 143 Saudi nurses in intensive care, oncology, and emergency units finds that hospital ethical climate is ...
A three-round European e-Delphi study has produced seventy consensus statements defining the role of specialist palliative care services for people ...
A prospective study of nearly 1,900 patients in China has developed and temporally validated a six-factor prediction model for catheter-associated ...
A schema-enforced large language model framework achieved 94 percent reproducibility across simulated sarcoma tumor board decisions, a leap over earlier ...
A multicenter study found that a deep learning model analyzing full ultrasound videos significantly improved diagnostic accuracy for suspicious breast ...
A McGill University study in Nature finds that certain obesogenic diets improved immunotherapy responses in mice through diet–microbiome synergy, suggesting ...
A computational model of hospital oncology units shows that asymptomatic carriers, not symptomatic patients, account for most C. difficile transmissions.
A qualitative interview study of cancer patients and caregivers in Saudi Arabia reveals that superficial search habits, trust in peer ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine